Priming with EGFR tyrosine kinase inhibitor and EGF sensitizes ovarian cancer cells to respond to chemotherapeutical drugs

Cancer Letters (2008) - Comments
pubmed: 18400375 doi: 10.1016/j.canlet.2008.02.062 issn: 0304-3835

Cong Cao, Shan Lu, Alex Sowa, Rebecca Kivlin, Ashley Amaral, Wenming Chu, Hui Yang, Wen Di, Yinsheng Wan